Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.41 |
| ▸ | CYP4F2 | P78329 | 7/20 | 0.37 |
| ▸ | CYP4A11 | Q02928 | 7/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 4/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2800521 | 0.90 | MAPK1 (0.40) | ALDH1A1CYP4F2CYP4A11MAPK1MEN1 | |
| SCHEMBL3163627 | 0.81 | ALDH1A1 (0.34) | ALDH1A1MEN1KMT2AMAPTATM | |
| SCHEMBL28278254 | 0.80 | CYP2C19 (0.47) | ALDH1A1CYP4F2CYP4A11MEN1KMT2A | |
| SCHEMBL6629750 | 0.76 | CYP4F2 (0.49) | ALDH1A1CYP4F2CYP4A11MEN1KMT2A | |
| SCHEMBL25174478 | 0.75 | MAPK1 (0.41) | ALDH1A1MAPK1MEN1KMT2AMAPT | |
| SCHEMBL28251465 | 0.74 | KDM4E (0.33) | ALDH1A1MEN1KMT2AKDM4ELMNA | |
| SCHEMBL28501410 | 0.73 | PTGER2 (0.40) | ALDH1A1CYP4F2CYP4A11MAPK1MEN1 | |
| SCHEMBL2037209 | 0.73 | CYP2C19 (0.33) | MEN1KMT2ACPB2 | |
| SCHEMBL6519623 | 0.73 | CYP2D6 (0.56) | ALDH1A1MAPK1MEN1KMT2ACYP1A2 | |
| SCHEMBL29215638 | 0.73 | USP2 (0.43) | CYP4F2CYP4A11ATMKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2430023-A1 | AZACYCLIC SPIRODERIVATIVES AS HSL INHIBITORS | F. Hoffmann-La Roche AG (CH) | 2012-03-21 | — | — | EP | disclosed |
| WO-2010130665-A1 | AZACYCLIC SPIRODERIVATIVES AS HSL INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2010-11-18 | — | — | WO | disclosed |